DISCOVERY GENOMICS

Coronavirus disease (also called COVID-19) is an infection caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus), one of the most recently discovered types of coronaviruses.

COVID-19 spreads from person-to-person. When an infected person coughs, sneezes, or exhales, droplets containing the virus go into the air and onto surfaces and objects around them. Other people are exposed to the virus by breathing in these droplets or by touching their eyes, nose, or mouth after touching infected surfaces.

PCR stands for Polymerase Chain Reaction. PCR tests are considered the “gold standard” diagnostic testing intended for the qualitative detection of nucleic acid from SARS-CoV-2.

We measure the accuracy of our test using two metrics: sensitivity and specificity. Below are the sensitivity and specificity for our test and a brief description of what each means:

•  90% Sensitivity - the test will correctly return a positive result for 90% of people who have the disease and will return a negative result — a false-negative — for 10% of the people who have the disease and should have tested positive.
•  100% Specificity - the test will correctly return a negative result for 100% of people who don't have the disease and will return a positive result — a false-positive — for 0% of the people who don't have the disease and should have tested negative.

Yes, it is authorized under the FDA’s Emergency Use Authorization (EUA).

Instructions for Discovery Genomics PCR Nasal Test